TREATMENT OF HEPATIC VENOOCCLUSIVE DISEASE WITH RECOMBINANT HUMAN TISSUE PLAMINOGEN ACTIVATOR OR ORTHOTOPIC LIVER TRANSPLANTATION AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION1

Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia

1986 • 1,453 citations

VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATION

1987 • 898 citations

Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors

1984 • 845 citations

The syndrome of hepatic veno-occlusive disease after marrow transplantation

1995 • 475 citations

A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group

1994 • 341 citations

Liver transplantation across ABO blood group barriers

1990 • 298 citations

Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial [see comments]

1992 • 190 citations

Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings.

1995 • 186 citations

Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules.

1987 • 184 citations

Thrombolytic therapy in the eighties

1986 • 177 citations

Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial [see comments]

1992 • 163 citations

Randomized trial of late elective angioplasty versus conservative management for patients with residual stenoses after thrombolytic treatment of myocardial infarction. Treatment of Post-Thrombolytic Stenoses (TOPS) Study Group.

1992 • 126 citations

Recombinant human tissue plasminogen activator for the treatment of established severe venocclusive disease of the liver after bone marrow transplantation

1992 • 101 citations

Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: Report of an initial experience

1989 • 72 citations

Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogeneic bone marrow transplant.

1991 • 62 citations

Veno-occlusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen activator (rt-PA).

1990 • 58 citations

SUCCESSFUL TREATMENT OF HEPATIC VENOOCCLUSIVE DISEASE IN A BONE MARROW TRANSPLANT PATIENT WITH ORTHOTOPIC LIVER TRANSPLANTATION

1990 • 55 citations

Hepatic veno-occlusive disease after bone marrow transplant

1993 • 53 citations

Cyclosporine bioavailability in heart-lung transplant candidates with cystic fibrosis.

1990 • 48 citations

Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation--clinical and immunological considerations.

1995 • 47 citations

Orthotopic liver transplantation for graft-versus-host disease following bone marrow transplantation

1990 • 41 citations

CYCLOSPORINE BIOAVAILABILITY IN HEART-LUNG TRANSPLANT CANDIDATES WITH CYSTIC FIBROSIS

1990 • 38 citations

Increased Mortality by Septicemia, Interstitial Pneumonitis and Pulmonary Fibrosis Among Bone Marrow Transplant Recipients Receiving an Increased Mean Dose Rate of Total Irradiation

1983 • 38 citations

Successful Treatment of Hepatic Venocclusive Disease in a Bone Marrow Transplant Patient With Side-to-Side Portacaval Shunt

1987 • 31 citations

Requirement of heparin for arterial and venous thrombolysis with recombinant tissue-type plasminogen activator

1991 • 30 citations

Recombinant tissue plasminogen activator (rt‐PA) for veno‐occlusive liver disease in pediatric autologous bone marrow transplant patients

1994 • 28 citations

Orthotopic liver transplantation for hepatic GVHD following allogeneic BMT for chronic myeloid leukaemia.

1992 • 21 citations

Reversal of severe hepatic veno-occlusive disease by combined plasma exchange and rt-PA treatment.

1995 • 10 citations

Effect of Ionizing Radiation on Liver Microcirculation and Oxygenation

1976 • 7 citations

Recombinant tissue plasminogen activator (rTPA) for hepatic veno-occlusive disease after allogeneic BMT in a pediatric patient.

1995 • 6 citations

Successful treatment of veno-occlusive disease with recombinant tissue plasminogen activator in a patient requiring peritoneal dialysis.

1994 • 5 citations

Fatal hemorrhage after recombinant tissue plasminogen activator therapy for hepatic veno-occlusive disease complicating autologous BMT.

1994 • 4 citations

EFFECTS OF ALLOGENIC LYMPHOCYTES ON INDUCTION OF TOLERANCE IN ANTILYMPHOCYTE GLOBULIN-TREATED X-IRRADIATED RATS

1970 • 3 citations

Cited By (0)

Loading...